Claims for Patent: 10,016,415
✉ Email this page to a colleague
Summary for Patent: 10,016,415
| Title: | Aripiprazole prodrug compositions |
| Abstract: | Described is a composition comprising (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of less than 1000 nm and (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilization of the aripiprazole prodrug. The surface stabilizer to prodrug ratio provides the optimal quantity of free surface stabilizer for the purposes of producing a lead-in formulation. Also described are methods of treatment using the aforementioned composition. |
| Inventor(s): | Philip Cresswell, Sara Montminy Paquette, Magali Hickey, Kristopher Perkin, Greg Smith, Elaine Liversidge, Brian Steinberg, David Manser, Ryan Turncliff, Michael Palmieri, Jr., Tarek Zeidan, Ethan P. Cash, Marjie L. Hard |
| Assignee: | Alkermes Pharma Ireland Ltd |
| Application Number: | US14/828,229 |
| Patent Claims: |
1. A composition consisting of polysorbate 20 and a population of particles of the formula: having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of said particles to polysorbate 20 is 17:1. 2. A composition consisting of polysorbate 20, a chelating agent, a tonicity agent, an aqueous buffer, and a population of particles of the formula: having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of the particles to polysorbate 20 is 17:1. 3. The composition of claim 2, wherein the chelating agent is sodium citrate. 4. The composition of claim 2, wherein the tonicity agent is sodium chloride. 5. A composition consisting of polysorbate 20, sodium citrate, sodium chloride, an aqueous buffer, and a population of particles of the formula: having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of the particles to polysorbate 20 is 17:1. 6. A composition consisting of: (a) about 26 weight percent of a compound of the following formula: (b) 1.53 weight percent polysorbate 20; (c) 0.76 weight percent sodium citrate; (d) 0.31 weight percent sodium chloride; and (e) an aqueous buffer, wherein the compound is provided as a population of particles having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques. 7. The composition of claim 6, wherein the ratio of the particles to polysorbate 20 is 17:1. 8. The composition of claim 2, wherein the composition is an aqueous dispersion. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
